Medima P300 Top _verified_
12 adjustable pressure levels (50–900 mmHg) with automatic bolus reduction after occlusion. Connectivity: Fully integrates with hospital data systems (HIS/PDMS) via MedimaNet software for centralized alarm monitoring and therapy records. Operational Benefits
What distinguishes the P300 from its predecessors (P100 and P200) is its focus on Drug Error Reduction Systems (DERS) and specialized infusion modes: Volumetric Infusion Pumps - Warszawa - MEDIMA
The standout feature of the P300 is its comprehensive drug library. Unlike more basic models (like the P100 or P200), the P300 allows hospitals to store up to 5,000 dosing procedures Drug Error Reduction System (DERS)
Patient safety remains the core focus of the P300's architecture. The device features an advanced, easy-to-use drug library that helps prevent medication errors. It works alongside specialized Medima Line IV administration sets , which feature integrated Free Flow Protection Clamps (FFPC) to completely eliminate accidental free-flow hazards during set changes. Continuous occlusion monitoring and multi-tiered alarm arrays warn staff of any inline pressure spikes instantly. Comparative Overview: Medima Pump Lineup To see how the medima p300 top
The Medima P300 Top is robust, but neglect will kill any hydraulic component. Follow this OEM-recommended schedule:
Supports various modes including ml/h, ml/min, time-based, volume-based, piggyback, profile (24 cycles), and TPN.
: Weighs less than 2.2 kg and includes an internal battery providing up to 15 hours of operation. Comparison of Medima P-Series Model P100 Model P200 Model P300 Basic Infusion Continuous (mL/h) Advanced Modes Intermittent, Profile, Ramp Intermittent, Profile, Ramp Drug Library Yes (Up to 6,000 protocols) TCI/TIVA Available as extension 12 adjustable pressure levels (50–900 mmHg) with automatic
: An internal rechargeable NiMH battery delivers up to 15 hours of operation during transport or power outages.
is a sophisticated volumetric infusion pump designed to meet the rigorous demands of intensive care and general hospital wards. Manufactured in Poland, it represents the high-end tier of the Medima P-series, offering advanced drug safety features and seamless hospital integration. Key Performance Specifications
| Department / Use Case | Key Requirements Addressed by P300 | | :--- | :--- | | | Precise, stable, low-flow-rate infusions of critical medications over extended periods | | Operating Theaters | Option for advanced TCI/TIVA modules, key for anesthesia | | Neonatology & Pediatrics | High accuracy at extremely low flow rates (0.1 - 99.99 mL/h) | | General Wards | Intuitive drug library with safety limits helps reduce bedside medication errors | | Emergency Transport | Robust design and internal battery that provides approximately 15 hours of runtime | Unlike more basic models (like the P100 or
Most homeowners and facility managers default to wall-mounted splits. However, the solves three critical problems that wall units cannot:
Before purchasing a , ensure your building meets these criteria:
The device utilizes an advanced that serves as a core safeguard. Hospital administrators can define custom drug parameters, including explicit hard limits (which cannot be bypassed) and soft limits (which trigger warnings but permit continuation). These parameters are segmented into distinct Clinical Care Areas (CCAs), mapping configurations directly to specialized needs in neonatal, pediatric, or intensive care environments. Structural Anti-Free-Flow Features
Positioned as the "top" of the line, the P300 builds upon the capabilities of its predecessors, incorporating advanced features that significantly enhance infusion safety and clinical versatility. It is a versatile, single-channel pump designed for precise intravenous and intra-arterial infusions in various hospital settings, from general wards to intensive care units (ICUs) and operating theaters. The device’s design philosophy centers on three core pillars: exceptional safety, user-centric operation, and reliable performance.
